1. Local disorder of the C-terminal segment of the heavy chain as a common sign of stressed antibodies evidenced with a peptide affinity probe specific to non-native IgG
- Author
-
Hideki Watanabe, Shinya Honda, and Takamitsu Miyafusa
- Subjects
Protein Denaturation ,Peptide ,02 engineering and technology ,Biochemistry ,Protein–protein interaction ,Mice ,03 medical and health sciences ,Structural Biology ,Animals ,Humans ,Denaturation (biochemistry) ,Artificial protein ,Molecular Biology ,030304 developmental biology ,chemistry.chemical_classification ,0303 health sciences ,Heavy chain ,biology ,Chemistry ,General Medicine ,021001 nanoscience & nanotechnology ,Rats ,Biopharmaceutical ,Immunoglobulin G ,biology.protein ,Rabbits ,Antibody ,Peptides ,0210 nano-technology ,Protein Binding - Abstract
Therapeutic antibodies have many biopharmaceutical applications; however, characterization of their higher-order structures is a major concern in quality control. We have developed AF.2A1, an artificial protein, that specifically recognizes non-native, structured IgGs. We performed binding assays using various types of IgGs and fragments to investigate the mechanisms by which AF.2A1 interacts with the non-native IgG. AF.2A1 recognized the acid-stressed IgGs from human, mouse, and rat, but not rabbit. Binding assays using the human IgG1 fragments revealed that an interface emerged by deleting five C-terminal residues. We conclude that AF.2A1 recognizes an exposed hydrophobic core centered on the Trp417. Our results concur with those of the previous studies showing that C-terminal structural changes occur early during antibody denaturation and aggregation. Our findings explain the molecular rationale for using AF.2A1 in quality control of biopharmaceutical IgGs.
- Published
- 2021
- Full Text
- View/download PDF